Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis
• Giant Cell Arteritis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Polyarteritis Nodosa
• Takayasu Arteritis

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS) | Phase 2 | Status: COMPLETED